The copyright and The Pharmaceutical Industry: A Risky Bet?

The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial launch generated substantial returns, the expiration of its exclusive rights opened the door to generic alternatives, dramatically diminishing sales. This creates a unique challenge for firms depending on related blockbuster products, suggesti

read more

High Gambler's Sildenafil: A Dangerous Wager

The emergence of so-called "High Luxury Viagra" – often referring to exceptionally high doses prescribed by disreputable physicians – represents a unusually alarming trend. While typical dosages of Viagra are intended for treating erectile dysfunction safely in most men, these significantly elevated quantities pose a significant threat to heart

read more